Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel

Gynecol Obstet Invest. 1990;30(2):114-9. doi: 10.1159/000293230.

Abstract

Intermittent treatment with an acid lactate gel (Lactal, ACO, Sweden) reduced symptoms of bacterial vaginosis (BV) and promoted the reestablishment of the normal vaginal flora of lactobacilli. Forty-two women seriously affected by recurrent BV were initially given acid gel (lactate gel, pH 3.8, 5 ml) to be inserted into the vagina daily for 7 consecutive days. Thereafter they entered into a double blind clinical trial and were treated prophylactically 3 days monthly for 6 months with either lactate gel or a placebo gel. Women treated with the lactate gel were clinically improved, i.e. no signs of BV in 88% compared to 10% in the placebo group (p less than 0.001). The vaginal lactobacilli flora was reestablished in 83% of the lactate group and in 16% of the placebo group. Local intermittent application of lactate gel was found to be free of side effects and is a preferable alternative to repeated treatments with antibiotics in patients with recurrent BV.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Animals
  • Female
  • Gels
  • Humans
  • Hydrogen-Ion Concentration
  • Lactates / administration & dosage
  • Lactates / therapeutic use*
  • Lactic Acid
  • Vagina / microbiology
  • Vagina / physiopathology
  • Vaginitis / drug therapy
  • Vaginitis / prevention & control*

Substances

  • Gels
  • Lactates
  • Lactic Acid